326 related articles for article (PubMed ID: 30576442)
1. Molecular signatures of X chromosome inactivation and associations with clinical outcomes in epithelial ovarian cancer.
Winham SJ; Larson NB; Armasu SM; Fogarty ZC; Larson MC; McCauley BM; Wang C; Lawrenson K; Gayther S; Cunningham JM; Fridley BL; Goode EL
Hum Mol Genet; 2019 Apr; 28(8):1331-1342. PubMed ID: 30576442
[TBL] [Abstract][Full Text] [Related]
2. An integrative approach to assess X-chromosome inactivation using allele-specific expression with applications to epithelial ovarian cancer.
Larson NB; Fogarty ZC; Larson MC; Kalli KR; Lawrenson K; Gayther S; Fridley BL; Goode EL; Winham SJ
Genet Epidemiol; 2017 Dec; 41(8):898-914. PubMed ID: 29119601
[TBL] [Abstract][Full Text] [Related]
3. Analysis of expressed SNPs identifies variable extents of expression from the human inactive X chromosome.
Cotton AM; Ge B; Light N; Adoue V; Pastinen T; Brown CJ
Genome Biol; 2013 Nov; 14(11):R122. PubMed ID: 24176135
[TBL] [Abstract][Full Text] [Related]
4. Chromosome-wide DNA methylation analysis predicts human tissue-specific X inactivation.
Cotton AM; Lam L; Affleck JG; Wilson IM; Peñaherrera MS; McFadden DE; Kobor MS; Lam WL; Robinson WP; Brown CJ
Hum Genet; 2011 Aug; 130(2):187-201. PubMed ID: 21597963
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation profiles of human active and inactive X chromosomes.
Sharp AJ; Stathaki E; Migliavacca E; Brahmachary M; Montgomery SB; Dupre Y; Antonarakis SE
Genome Res; 2011 Oct; 21(10):1592-600. PubMed ID: 21862626
[TBL] [Abstract][Full Text] [Related]
6. X-inactivation in female human embryonic stem cells is in a nonrandom pattern and prone to epigenetic alterations.
Shen Y; Matsuno Y; Fouse SD; Rao N; Root S; Xu R; Pellegrini M; Riggs AD; Fan G
Proc Natl Acad Sci U S A; 2008 Mar; 105(12):4709-14. PubMed ID: 18339804
[TBL] [Abstract][Full Text] [Related]
7. Contribution of genetic and epigenetic changes to escape from X-chromosome inactivation.
Balaton BP; Brown CJ
Epigenetics Chromatin; 2021 Jun; 14(1):30. PubMed ID: 34187555
[TBL] [Abstract][Full Text] [Related]
8. The inactive X chromosome is epigenetically unstable and transcriptionally labile in breast cancer.
Chaligné R; Popova T; Mendoza-Parra MA; Saleem MA; Gentien D; Ban K; Piolot T; Leroy O; Mariani O; Gronemeyer H; Vincent-Salomon A; Stern MH; Heard E
Genome Res; 2015 Apr; 25(4):488-503. PubMed ID: 25653311
[TBL] [Abstract][Full Text] [Related]
9. Genetics and epigenetics of the X chromosome.
Morey C; Avner P
Ann N Y Acad Sci; 2010 Dec; 1214():E18-33. PubMed ID: 21382199
[TBL] [Abstract][Full Text] [Related]
10. Female human pluripotent stem cells rapidly lose X chromosome inactivation marks and progress to a skewed methylation pattern during culture.
Geens M; Seriola A; Barbé L; Santalo J; Veiga A; Dée K; Van Haute L; Sermon K; Spits C
Mol Hum Reprod; 2016 Apr; 22(4):285-98. PubMed ID: 26786180
[TBL] [Abstract][Full Text] [Related]
11. Skewed allelic expression on X chromosome associated with aberrant expression of XIST on systemic lupus erythematosus lymphocytes.
Zhang Y; Li X; Gibson A; Edberg J; Kimberly RP; Absher DM
Hum Mol Genet; 2020 Aug; 29(15):2523-2534. PubMed ID: 32628254
[TBL] [Abstract][Full Text] [Related]
12. Dysregulation of X chromosome inactivation in high grade ovarian serous adenocarcinoma.
Kang J; Lee HJ; Kim J; Lee JJ; Maeng LS
PLoS One; 2015; 10(3):e0118927. PubMed ID: 25742136
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic modification of the X chromosome influences susceptibility to polycystic ovary syndrome.
Hickey TE; Legro RS; Norman RJ
J Clin Endocrinol Metab; 2006 Jul; 91(7):2789-91. PubMed ID: 16636126
[TBL] [Abstract][Full Text] [Related]
14. The dynamic epigenetic regulation of the inactive X chromosome in healthy human B cells is dysregulated in lupus patients.
Pyfrom S; Paneru B; Knox JJ; Cancro MP; Posso S; Buckner JH; Anguera MC
Proc Natl Acad Sci U S A; 2021 Jun; 118(24):. PubMed ID: 34103397
[TBL] [Abstract][Full Text] [Related]
15. Sjögren's syndrome X-chromosome dose effect: An epigenetic perspective.
Mougeot JL; Noll BD; Bahrani Mougeot FK
Oral Dis; 2019 Mar; 25(2):372-384. PubMed ID: 29316023
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic and transcriptomic consequences of excess X-chromosome material in 47,XXX syndrome-A comparison with Turner syndrome and 46,XX females.
Nielsen MM; Trolle C; Vang S; Hornshøj H; Skakkebaek A; Hedegaard J; Nordentoft I; Pedersen JS; Gravholt CH
Am J Med Genet C Semin Med Genet; 2020 Jun; 184(2):279-293. PubMed ID: 32489015
[TBL] [Abstract][Full Text] [Related]
17. Cross-species examination of X-chromosome inactivation highlights domains of escape from silencing.
Balaton BP; Fornes O; Wasserman WW; Brown CJ
Epigenetics Chromatin; 2021 Feb; 14(1):12. PubMed ID: 33597016
[TBL] [Abstract][Full Text] [Related]
18. A unified partial likelihood approach for X-chromosome association on time-to-event outcomes.
Xu W; Hao M
Genet Epidemiol; 2018 Feb; 42(1):80-94. PubMed ID: 29178618
[TBL] [Abstract][Full Text] [Related]
19. Landscape of DNA methylation on the X chromosome reflects CpG density, functional chromatin state and X-chromosome inactivation.
Cotton AM; Price EM; Jones MJ; Balaton BP; Kobor MS; Brown CJ
Hum Mol Genet; 2015 Mar; 24(6):1528-39. PubMed ID: 25381334
[TBL] [Abstract][Full Text] [Related]
20. [X chromosome inactivation patterns in patients with Rett syndrome and their mothers and the parental origin of the priority inactive X chromosome].
Jiang SL; Bao XH; Song FY; Pan H; Li MR; Wu XR
Zhonghua Er Ke Za Zhi; 2006 Sep; 44(9):648-52. PubMed ID: 17217653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
